We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

80 hedge funds and large institutions have $73.9M invested in abrdn Life Sciences Investors in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

113% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 15

27% more funds holding

Funds holding: 63 → 80 (+17)

27% more capital invested

Capital invested by funds: $58.4M → $73.9M (+$15.5M)

3.74% more ownership

Funds ownership: 17.01% → 20.75% (+3.7%)

Holders
80
Holders Change
+17
Holders Change %
+26.98%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
1CP
1607 Capital Partners
Virginia
+$4.42M
2
LSC
Logan Stone Capital
Illinois
+$2.3M
3
Allspring Global Investments
Allspring Global Investments
North Carolina
+$2.26M
4
Bank of America
Bank of America
North Carolina
+$1.72M
5
RJA
Raymond James & Associates
Florida
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
NIM
Needham Investment Management
New York
-$2.19M
2
SI
Stephens Inc
Arkansas
-$1.12M
3
Wells Fargo
Wells Fargo
California
-$796K
4
LPL Financial
LPL Financial
California
-$507K
5
AAM
Advisors Asset Management
Colorado
-$286K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
AQR Arbitrage
Connecticut
$763K +$633K +43,681 +436%
UBS Group
27
UBS Group
Switzerland
$743K -$169K -11,696 -18%
Millennium Management
28
Millennium Management
New York
$702K +$205K +14,176 +40%
Walleye Capital
29
Walleye Capital
New York
$681K +$695K +47,955 New
AWS
30
Atria Wealth Solutions
New York
$556K -$167K -11,515 -23%
WP
31
Woodline Partners
California
$548K +$559K +38,584 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$539K +$71.5K +4,933 +15%
KWM
33
Kingsview Wealth Management
Oregon
$528K – – –
LCM
34
Landscape Capital Management
New Jersey
$492K -$150K -10,372 -23%
WAM
35
Weiss Asset Management
Massachusetts
$403K +$411K +28,350 New
Invesco
36
Invesco
Georgia
$396K -$213K -14,713 -35%
NA
37
NewEdge Advisors
Louisiana
$378K +$1.88K +130 +0.5%
EC
38
Elequin Capital
New York
$310K +$316K +21,806 New
QC
39
Quantedge Capital
Singapore
$245K +$249K +17,220 New
First Trust Advisors
40
First Trust Advisors
Illinois
$242K – – –
WS
41
Wedbush Securities
California
$238K +$35.5K +2,450 +17%
OC
42
Oppenheimer & Co
New York
$233K +$319 +22 +0.1%
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$232K +$237K +16,349 New
LOPW
44
Live Oak Private Wealth
North Carolina
$202K +$14.8K +1,021 +8%
SI
45
Stephens Inc
Arkansas
$198K -$1.12M -77,220 -85%
NFG
46
Nations Financial Group
Iowa
$198K – – –
EP
47
Eudaimonia Partners
Tennessee
$196K +$7.94K +548 +4%
TPWM
48
Twelve Points Wealth Management
Massachusetts
$186K -$6.16K -425 -3%
PIA
49
Powell Investment Advisors
Florida
$181K – – –
RJT
50
Raymond James Trust
Florida
$173K – – –
1
2
3 4

HQL Hedge Fund Activity: Q4 2022 in Review

80 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2022, worth a combined $73.9M — up 27% from $58.4M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new HQL positions and 3 closed out — a net gain of 17 holders — while 32 added to existing stakes and 15 trimmed.

The largest buyer was 1607 Capital Partners, adding an estimated $4.42M. The largest seller was Needham Investment Management, cutting an estimated $2.19M.

  • 80 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2022, up from 63 in Q3 2022.
  • Funds reported $73.9M of abrdn Life Sciences Investors stock for Q4 2022, up 27% quarter-over-quarter.
  • 20 funds opened new abrdn Life Sciences Investors positions in Q4 2022 and 3 closed out, a net change of +17 holders.
  • The largest abrdn Life Sciences Investors buyer in Q4 2022 was 1607 Capital Partners, an estimated $4.42M added.
  • The largest abrdn Life Sciences Investors seller in Q4 2022 was Needham Investment Management, an estimated $2.19M sold.

Based on aggregated 13F filings for Q4 2022.